Naomi Aronson

Executive Director, Clinical Evaluation, Innovation & Policy, Officer of Clinical Affairs

Blue Cross Blue Shield Association

Heather Ascani

Director, Business Operations, Applied Systems Biology Core

University of Michigan

George Bashirians

Senior Director & Diagnostics Lead

Pfizer

Gabriel Cohn

Vice President & Clinical Development Lead

AvroBio

John Dwyer

President

Global Alzheimer’s Platform Foundation

Mike Hutton

Chief Scientific Officer & Vice President, Neurodegeneration Research

Eli Lilly & Co.

Wenjun Ju

Deputy Director, George M. O’Brien Kidney Translational Core Center & Co-Director, UMHS-PUHSC Joint Institute for Translational & Clinical Research Renal Core

University of Michigan

Michael Kiebish

Chief Precision Medicine Officer & Vice President, Systems Medicine

Berg Health

Zhen Mahoney

Head, Business Development

Asuragen

Charles Mathews

Principal

ClearView Healthcare Partners

Michelle Mielke

Professor, Epidemiology & Neurology

Mayo Clinic

Vijay Modur

Global Project Head, Rare Disease Clinical Development

Sanofi Genzyme

Franziska Moeckel

Assistant Vice President, Personalized Health

Inova Health System

Spyros Papapetropoulos

Chief Medical Officer & Executive Vice President & Head, Research & Development

Cavion

John Reilly

Vice President, Biology

Goldfinch Bio

Kenneth Rhodes

Chief Scientific Officer

Yumanity Therapeutics

Gordon Vanscoy

Chairman & CEO

PANTHERx Specialty Pharmacy

Szilard Voros

Founder & Chief Executive Officer

Global Genomics Group

Speaker confirming

Covance